{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:29:49Z","timestamp":1789273789627,"version":"build-2803163510"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-04002-4","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:00:18Z","timestamp":1741842018000},"page":"9851-9872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel drug delivery systems in topical treatment of atopic dermatitis"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-4951","authenticated-orcid":false,"given":"Meghna","family":"Dabhadkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7809-9958","authenticated-orcid":false,"given":"Madhur","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"1","key":"4002_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bfopcu.2016.12.003","volume":"55","author":"N Akhtar","year":"2017","unstructured":"Akhtar N, Verma A, Pathak K (2017) Exploring preclinical and clinical effectiveness of nanoformulations in the treatment of atopic dermatitis: Safety aspects and patent reviews. Bull Fac Pharm Cairo Univ 55(1):1\u201310. https:\/\/doi.org\/10.1016\/j.bfopcu.2016.12.003","journal-title":"Bull Fac Pharm Cairo Univ"},{"issue":"1","key":"4002_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.dit.2013.02.001","volume":"5","author":"MdS Alam","year":"2013","unstructured":"Alam MdS, Ali MdS, Alam N, Siddiqui MR, Shamim Md, Safhi MM (2013) In vivo study of clobetasol propionate loaded nanoemulsion for topical application in psoriasis and atopic dermatitis. Drug Invent Today 5(1):8\u201312. https:\/\/doi.org\/10.1016\/j.dit.2013.02.001","journal-title":"Drug Invent Today"},{"issue":"4","key":"4002_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1091581813487563","volume":"32","author":"S Alarifi","year":"2013","unstructured":"Alarifi S, Ali D, Verma A, Alakhtani S, Ali BA (2013) Cytotoxicity and genotoxicity of copper oxide nanoparticles in human skin keratinocytes cells. Int J Toxicol 32(4):296\u2013307. https:\/\/doi.org\/10.1177\/1091581813487563","journal-title":"Int J Toxicol"},{"issue":"4","key":"4002_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11096-023-01569-x","volume":"45","author":"C Alves","year":"2023","unstructured":"Alves C, Penedones A, Mendes D, Batel Marques F (2023) Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis. Int J Clin Pharm 45(4):830\u2013838. https:\/\/doi.org\/10.1007\/s11096-023-01569-x","journal-title":"Int J Clin Pharm"},{"key":"4002_CR5","doi-asserted-by":"publisher","DOI":"10.12932\/AP-010221-1050","author":"Anon.","year":"2021","unstructured":"Anon (2021) Clinical practice guidelines for the diagnosis and management of atopic dermatitis. Asian Pac J Allergy Immunol. https:\/\/doi.org\/10.12932\/AP-010221-1050","journal-title":"Asian Pac J Allergy Immunol"},{"key":"4002_CR6","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.2147\/CCID.S389697","volume":"15","author":"E Araviiskaia","year":"2022","unstructured":"Araviiskaia E, Pincelli C, Sparavigna A, Luger T (2022) The role of a novel generation of emollients, \u2018Emollients Plus\u2019, in atopic dermatitis. Clin Cosmet Investig Dermatol 15:2705\u20132719. https:\/\/doi.org\/10.2147\/CCID.S389697","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"4002_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/0973-8398.107558","volume":"6","author":"S Arora","year":"2012","unstructured":"Arora S, Lamba H, Tiwari R (2012) Dermal delivery of drugs using different vesicular carriers: a comparative review. Asian J Pharm 6(4):237. https:\/\/doi.org\/10.4103\/0973-8398.107558","journal-title":"Asian J Pharm"},{"issue":"2","key":"4002_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17425247.2017.1264386","volume":"14","author":"R Arora","year":"2017","unstructured":"Arora R, Katiyar SS, Kushwah V, Jain S (2017) Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin Drug Deliv 14(2):165\u2013177. https:\/\/doi.org\/10.1080\/17425247.2017.1264386","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"4002_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1208\/s12249-019-1355-6","volume":"20","author":"M Assem","year":"2019","unstructured":"Assem M, Khowessah OM, Ghorab D (2019) Optimization and evaluation of beclomethasone dipropionate micelles incorporated into biocompatible hydrogel using a sub-chronic dermatitis animal model. AAPS PharmSciTech 20(4):152. https:\/\/doi.org\/10.1208\/s12249-019-1355-6","journal-title":"AAPS PharmSciTech"},{"key":"4002_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/CCID.S141887","volume":"10","author":"M Augustin","year":"2017","unstructured":"Augustin M, Goepel L, Jacobi A, Bosse B, Mueller S, Hopp M (2017) Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study. Clin Cosmet Investig Dermatol 10:373\u2013384. https:\/\/doi.org\/10.2147\/CCID.S141887","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4002_CR11","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.nano.2019.102140","volume":"24","author":"A Badihi","year":"2020","unstructured":"Badihi A, Fru\u0161i\u0107-Zlotkin M, Soroka Y, Benhamron S, Tzur T, Nassar T, Benita S (2020) Topical nano-encapsulated cyclosporine formulation for atopic dermatitis treatment. Nanomedicine 24:102140. https:\/\/doi.org\/10.1016\/j.nano.2019.102140","journal-title":"Nanomedicine"},{"issue":"1","key":"4002_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","volume":"21","author":"T Bieber","year":"2022","unstructured":"Bieber T (2022) Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discovery 21(1):21\u201340. https:\/\/doi.org\/10.1038\/s41573-021-00266-6","journal-title":"Nat Rev Drug Discovery"},{"issue":"2","key":"4002_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2478\/cipms-2024-0016","volume":"37","author":"JD Borse","year":"2024","unstructured":"Borse JD, Pawar AY, Bendkule KB, Shinde PS (2024) Formulation and development of Tacrolimus nanosponges-loaded hydrogel for the treatment of atopic dermatitis. Curr Issues Pharm Med Sci 37(2):96\u2013104. https:\/\/doi.org\/10.2478\/cipms-2024-0016","journal-title":"Curr Issues Pharm Med Sci"},{"issue":"6","key":"4002_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/jdv.18008","volume":"36","author":"AL Bosma","year":"2022","unstructured":"Bosma AL, Ascott A, Iskandar R, Farquhar K, Matthewman J, Langendam MW, Mulick A, Abuabara K, Williams HC, Spuls PI, Langan SM, Middelkamp-Hup MA (2022) Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics. J Eur Acad Dermatol Venereol 36(6):807\u2013819. https:\/\/doi.org\/10.1111\/jdv.18008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"4002_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jaad.2019.05.100","volume":"81","author":"DS Braswell","year":"2019","unstructured":"Braswell DS, Hakeem A, Walker A, Sokumbi O, Kapil J, Motaparthi K (2019) Lichenoid granulomatous dermatitis revisited: a retrospective case series. J Am Acad Dermatol 81(5):1157\u20131164. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.100","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"4002_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","volume":"15","author":"WW Carr","year":"2013","unstructured":"Carr WW (2013) Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Pediatr Drugs 15(4):303\u2013310. https:\/\/doi.org\/10.1007\/s40272-013-0013-9","journal-title":"Pediatr Drugs"},{"issue":"3","key":"4002_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1573396314666180613083616","volume":"14","author":"N Cartledge","year":"2018","unstructured":"Cartledge N, Chan S (2018) Atopic dermatitis and food allergy: a paediatric approach. Curr Pediatr Rev 14(3):171\u2013179. https:\/\/doi.org\/10.2174\/1573396314666180613083616","journal-title":"Curr Pediatr Rev"},{"issue":"5","key":"4002_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/00914037.2018.1443932","volume":"68","author":"S Chauhan","year":"2019","unstructured":"Chauhan S, Gulati N, Nagaich U (2019) Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery. Int J Polym Mater Polym Biomater 68(5):266\u2013277. https:\/\/doi.org\/10.1080\/00914037.2018.1443932","journal-title":"Int J Polym Mater Polym Biomater"},{"issue":"2","key":"4002_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.34172\/apb.2020.021","volume":"10","author":"I Chauhan","year":"2020","unstructured":"Chauhan I, Yasir M, Verma M, Singh AP (2020) Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharm Bull 10(2):150\u2013165. https:\/\/doi.org\/10.34172\/apb.2020.021","journal-title":"Adv Pharm Bull"},{"issue":"1\u20132","key":"4002_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijpharm.2012.03.042","volume":"430","author":"G Chen-yu","year":"2012","unstructured":"Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z (2012) Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm 430(1\u20132):292\u2013298. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.042","journal-title":"Int J Pharm"},{"key":"4002_CR21","doi-asserted-by":"publisher","first-page":"104878","DOI":"10.1016\/j.phrs.2020.104878","volume":"158","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi A, Comberiati P, D\u2019Auria E, Zuccotti G, Peroni DG (2020) Topical corticosteroids for pediatric atopic dermatitis: thoughtful tips for practice. Pharmacol Res 158:104878. https:\/\/doi.org\/10.1016\/j.phrs.2020.104878","journal-title":"Pharmacol Res"},{"issue":"5","key":"4002_CR22","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s13346-023-01307-w","volume":"13","author":"L-H Chuah","year":"2023","unstructured":"Chuah L-H, Loo H-L, Goh CF, Fu J-Y, Ng S-F (2023) Chitosan-based drug delivery systems for skin atopic dermatitis: recent advancements and patent trends. Drug Deliv Transl Res 13(5):1436\u20131455. https:\/\/doi.org\/10.1007\/s13346-023-01307-w","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"4002_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08982100902736571","volume":"19","author":"B Clares","year":"2009","unstructured":"Clares B, Gallardo V, Medina M, Ruiz M (2009) Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization. J Liposome Res 19(3):197\u2013206. https:\/\/doi.org\/10.1080\/08982100902736571","journal-title":"J Liposome Res"},{"key":"4002_CR24","doi-asserted-by":"publisher","first-page":"121656","DOI":"10.1016\/j.ijpharm.2022.121656","volume":"618","author":"A Cl\u00e1udia Paiva-Santos","year":"2022","unstructured":"Cl\u00e1udia Paiva-Santos A, Gama M, Peixoto D, Sousa-Oliveira I, Ferreira-Faria I, Zeinali M, Abbaspour-Ravasjani S, Mascarenhas-Melo F, Hamishehkar H, Veiga F (2022) Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. Int J Pharm 618:121656. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121656","journal-title":"Int J Pharm"},{"key":"4002_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/DDDT.S426947","volume":"18","author":"M Cork","year":"2024","unstructured":"Cork M, Danby S, Rossi AB, Bansal A (2024) Dupilumab treatment in pediatric patients aged 6\u201311 years with severe atopic dermatitis whose disease is not adequately controlled: a review. Drug des Dev Ther 18:277\u2013289. https:\/\/doi.org\/10.2147\/DDDT.S426947","journal-title":"Drug des Dev Ther"},{"key":"4002_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bioactmat.2019.11.003","volume":"4","author":"G Damiani","year":"2019","unstructured":"Damiani G, Eggenh\u00f6ffner R, Pigatto PDM, Bragazzi NL (2019) Nanotechnology meets atopic dermatitis: Current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature. Bioact Mater 4:380\u2013386. https:\/\/doi.org\/10.1016\/j.bioactmat.2019.11.003","journal-title":"Bioact Mater"},{"issue":"8","key":"4002_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s13204-017-0634-3","volume":"7","author":"V Dave","year":"2017","unstructured":"Dave V, Sharma S, Yadav RB, Agarwal U (2017) Herbal liposome for the topical delivery of ketoconazole for the effective treatment of seborrheic dermatitis. Appl Nanosci 7(8):973\u2013987. https:\/\/doi.org\/10.1007\/s13204-017-0634-3","journal-title":"Appl Nanosci"},{"key":"4002_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","volume-title":"Management of Atopic Dermatitis","author":"W David Boothe","year":"2017","unstructured":"David Boothe W, Tarbox JA, Tarbox MB (2017) Atopic dermatitis: pathophysiology. In: Fortson EA, Feldman SR, Strowd LC (eds) Management of Atopic Dermatitis. Springer International Publishing, Cham, pp 21\u201337"},{"issue":"3","key":"4002_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/jid.2011.435","volume":"132","author":"A De Benedetto","year":"2012","unstructured":"De Benedetto A, Kubo A, Beck LA (2012) Skin barrier disruption: a requirement for allergen sensitization? J Investig Dermatol 132(3):949\u2013963. https:\/\/doi.org\/10.1038\/jid.2011.435","journal-title":"J Investig Dermatol"},{"key":"4002_CR30","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6989","author":"D Deleanu","year":"2018","unstructured":"Deleanu D, Nedelea I (2018) Biological therapies for atopic dermatitis: an update (Review). Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2018.6989","journal-title":"Exp Ther Med"},{"key":"4002_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.25259\/IJDVL_14_2023","volume":"90","author":"S Dhar","year":"2023","unstructured":"Dhar S, Datta S, De A (2023) Use of Janus kinase inhibitors in atopic dermatitis \u2013 an update. Indian J Dermatol Venereol Leprol 90:311\u2013317. https:\/\/doi.org\/10.25259\/IJDVL_14_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"4002_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s10965-017-1342-0","volume":"24","author":"VJ Drew","year":"2017","unstructured":"Drew VJ, Huang H-Y, Tsai Z-H, Tsai H-H, Tseng C-L (2017) Preparation of gelatin\/epigallocatechin gallate self-assembly nanoparticles for transdermal drug delivery. J Polym Res 24(11):188. https:\/\/doi.org\/10.1007\/s10965-017-1342-0","journal-title":"J Polym Res"},{"issue":"1","key":"4002_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","volume":"71","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Sidbury R (2014) Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol 71(1):116\u2013132. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.023","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4002_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.anai.2022.01.012","volume":"128","author":"PM Elias","year":"2022","unstructured":"Elias PM (2022) Optimizing emollient therapy for skin barrier repair in atopic dermatitis. Ann Allergy Asthma Immunol 128(5):505\u2013511. https:\/\/doi.org\/10.1016\/j.anai.2022.01.012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"4002_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ijwd.2021.07.005","volume":"7","author":"S Elsgaard","year":"2021","unstructured":"Elsgaard S, Danielsen AK, Thyssen JP, Deleuran M, Vestergaard C (2021) Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort. Int J Womens Dermatol 7(5):708\u2013715. https:\/\/doi.org\/10.1016\/j.ijwd.2021.07.005","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"4002_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/pharmaceutics12030255","volume":"12","author":"LC Espinoza","year":"2020","unstructured":"Espinoza LC, Vera-Garc\u00eda R, Silva-Abreu M, Dom\u00e8nech \u00d2, Badia J, Rodr\u00edguez-Lagunas MJ, Clares B, Calpena AC (2020) Topical Pioglitazone nanoformulation for the treatment of atopic dermatitis: design, characterization and efficacy in hairless mouse model. Pharmaceutics 12(3):255. https:\/\/doi.org\/10.3390\/pharmaceutics12030255","journal-title":"Pharmaceutics"},{"issue":"9","key":"4002_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/life11090962","volume":"11","author":"I Fer\u010dek","year":"2021","unstructured":"Fer\u010dek I, Lugovi\u0107-Mihi\u0107 L, Tambi\u0107-Andra\u0161evi\u0107 A, \u0106esi\u0107 D, Grgini\u0107 AG, Be\u0161li\u0107 I, Mravak-Stipeti\u0107 M, Mihatov-\u0160tefanovi\u0107 I, Bunti\u0107 A-M, \u010civljak R (2021) Features of the skin microbiota in common inflammatory skin diseases. Life 11(9):962. https:\/\/doi.org\/10.3390\/life11090962","journal-title":"Life"},{"key":"4002_CR38","doi-asserted-by":"publisher","first-page":"121144","DOI":"10.1016\/j.ijpharm.2021.121144","volume":"609","author":"V Ferrari Cervi","year":"2021","unstructured":"Ferrari Cervi V, Parcianello Saccol C, Henrique Marcondes Sari M, Crist\u00f3v\u00e3o Martins C, Saldanha Da Rosa L, Dias Ilha B, Zovico Soares F, Luchese C, Antunes Wilhelm E, Cruz L (2021) Pullulan film incorporated with nanocapsules improves pomegranate seed oil anti-inflammatory and antioxidant effects in the treatment of atopic dermatitis in mice. Int J Pharm 609:121144. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121144","journal-title":"Int J Pharm"},{"key":"4002_CR39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jpeds.2020.02.015","volume":"221","author":"AB Fishbein","year":"2020","unstructured":"Fishbein AB, Hamideh N, Lor J, Zhao S, Kruse L, Mason M, Ariza A, Bolanos L, Necheles J, Kaye B (2020) Management of atopic dermatitis in children younger than two years of age by community pediatricians: a survey and chart review. J Pediatr 221:138-144.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2020.02.015","journal-title":"J Pediatr"},{"issue":"1\u20132","key":"4002_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2014.06.039","volume":"472","author":"Z F\u00fcl\u00f6p","year":"2014","unstructured":"F\u00fcl\u00f6p Z, Saokham P, Loftsson T (2014) Sulfobutylether-\u03b2-cyclodextrin\/chitosan nano- and microparticles and their physicochemical characteristics. Int J Pharm 472(1\u20132):282\u2013287. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.039","journal-title":"Int J Pharm"},{"issue":"4","key":"4002_CR41","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1208\/s12249-013-0017-3","volume":"14","author":"S Goindi","year":"2013","unstructured":"Goindi S, Kumar G, Kumar N, Kaur A (2013) Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech 14(4):1284\u20131293. https:\/\/doi.org\/10.1208\/s12249-013-0017-3","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"4002_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13643-020-01472-w","volume":"9","author":"LG G\u00f3mez-Escobar","year":"2020","unstructured":"G\u00f3mez-Escobar LG, Mora-Ochoa H, Vargas Villanueva A, Spineli L, Sanclemente G, Couban R, Garc\u00eda E, Chapman E, Yepes-Nu\u00f1ez JJ (2020) Effectiveness and adverse events of topical and allergen immunotherapy for atopic dermatitis: a systematic review and network meta-analysis protocol. Syst Rev 9(1):222. https:\/\/doi.org\/10.1186\/s13643-020-01472-w","journal-title":"Syst Rev"},{"issue":"1","key":"4002_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13555-018-0223-8","volume":"8","author":"WC Gordon","year":"2018","unstructured":"Gordon WC, L\u00f3pez VG, Bhattacharjee S, Gil DR, D\u00edaz JA, De La Losa FP, Pel\u00e1ez RP, Ferrer CT, Bacchini GS, Jun B, Varoqui H, Bazan NG (2018) A nonsteroidal novel formulation targeting inflammatory and pruritus-related mediators modulates experimental allergic contact dermatitis. Dermatol Ther 8(1):111\u2013126. https:\/\/doi.org\/10.1007\/s13555-018-0223-8","journal-title":"Dermatol Ther"},{"issue":"8","key":"4002_CR44","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jdv.15618","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Zhang H, Liu Q, Wei F, Tang J, Li P, Han X, Zou X, Xu G, Xu Z, Zong W, Ran Q, Xiao F, Mu Z, Mao X, Ran N, Cheng R, Li M, Li C, Luo Y, Meng C, Zhang X, Xu H, Li J, Tang P, Xiang J, Shen C, Niu H, Li H, Shen J, Ni C, Zhang J, Wang H, Ma L, Bieber T, Yao Z (2019) Phenotypic analysis of atopic dermatitis in children aged 1\u201312 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence. J Eur Acad Dermatol Venereol 33(8):1569\u20131576. https:\/\/doi.org\/10.1111\/jdv.15618","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4002_CR45","doi-asserted-by":"publisher","first-page":"adv00869","DOI":"10.2340\/actadv.v103.5346","volume":"103","author":"Y Han","year":"2023","unstructured":"Han Y, Woo YR, Cho SH, Lee JD, Kim HS (2023) Itch and janus kinase inhibitors. Acta Dermato-Venereologica 103:adv00869. https:\/\/doi.org\/10.2340\/actadv.v103.5346","journal-title":"Acta Dermato-Venereologica"},{"key":"4002_CR46","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55393","author":"TD Hernandez","year":"2024","unstructured":"Hernandez TD, Aleman SJ, Bao-Loc-Trung M, Forte MV, Brandt W, Armstrong C, Howard J, Mosieri CN, Ahmadzadeh S, Varrassi G, Shekoohi S, Kaye AD (2024) Advancing treatment in atopic dermatitis: a comprehensive review of clinical efficacy, safety, and comparative insights into corticosteroids, calcineurin inhibitors, and phosphodiesterase-4 inhibitors as topical therapies. Cureus. https:\/\/doi.org\/10.7759\/cureus.55393","journal-title":"Cureus"},{"issue":"3","key":"4002_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/jps.23446","volume":"102","author":"Z Hussain","year":"2013","unstructured":"Hussain Z, Katas H, Amin MCIM, Kumulosasi E, Sahudin S (2013) Antidermatitic perspective of hydrocortisone as chitosan nanocarriers: an ex vivo and in vivo assessment using an NC\/Nga mouse model. J Pharm Sci 102(3):1063\u20131075. https:\/\/doi.org\/10.1002\/jps.23446","journal-title":"J Pharm Sci"},{"issue":"1","key":"4002_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/25785826.2019.1628467","volume":"42","author":"K Igawa","year":"2019","unstructured":"Igawa K (2019) Future trends in the treatment of atopic dermatitis. Immunol Med 42(1):10\u201315. https:\/\/doi.org\/10.1080\/25785826.2019.1628467","journal-title":"Immunol Med"},{"issue":"1","key":"4002_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00420-021-01781-0","volume":"95","author":"G Jacobsen","year":"2022","unstructured":"Jacobsen G, Rasmussen K, Bregnh\u00f8j A, Isaksson M, Diepgen TL, Carstensen O (2022) Causes of irritant contact dermatitis after occupational skin exposure: a systematic review. Int Arch Occup Environ Health 95(1):35\u201365. https:\/\/doi.org\/10.1007\/s00420-021-01781-0","journal-title":"Int Arch Occup Environ Health"},{"issue":"1","key":"4002_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/08982104.2022.2085742","volume":"33","author":"A Jafari","year":"2023","unstructured":"Jafari A, Daneshamouz S, Ghasemiyeh P, Mohammadi-Samani S (2023) Ethosomes as dermal\/transdermal drug delivery systems: applications, preparation and characterization. J Liposome Res 33(1):34\u201352. https:\/\/doi.org\/10.1080\/08982104.2022.2085742","journal-title":"J Liposome Res"},{"issue":"3","key":"4002_CR51","doi-asserted-by":"publisher","first-page":"e06621","DOI":"10.1016\/j.heliyon.2021.e06621","volume":"7","author":"I Jahan","year":"2021","unstructured":"Jahan I, Islam MdR, Islam MdR, Ali R, Rahman SMM, Nahar Z, Hasnat A, Islam MdS (2021) Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis. Heliyon 7(3):e06621. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06621","journal-title":"Heliyon"},{"issue":"8","key":"4002_CR52","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3109\/02652048.2014.932027","volume":"31","author":"A Jahn","year":"2014","unstructured":"Jahn A, Song CK, Balakrishnan P, Hong S-S, Lee J-H, Chung S-J, Kim D-D (2014) AAPE proliposomes for topical atopic dermatitis treatment. J Microencapsul 31(8):768\u2013773. https:\/\/doi.org\/10.3109\/02652048.2014.932027","journal-title":"J Microencapsul"},{"key":"4002_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/574673","volume":"2014","author":"S Jain","year":"2014","unstructured":"Jain S, Jain V, Mahajan SC (2014) Lipid based vesicular drug delivery systems. Adv Pharm 2014:1\u201312. https:\/\/doi.org\/10.1155\/2014\/574673","journal-title":"Adv Pharm"},{"issue":"1","key":"4002_CR54","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1515\/ntrev-2022-0109","volume":"11","author":"S Javed","year":"2022","unstructured":"Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W (2022) Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnol Rev 11(1):1744\u20131777. https:\/\/doi.org\/10.1515\/ntrev-2022-0109","journal-title":"Nanotechnol Rev"},{"key":"4002_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2016.07.008","volume":"128\u2013129","author":"J Jeevanandam","year":"2016","unstructured":"Jeevanandam J, Chan YS, Danquah MK (2016) Nano-formulations of drugs: recent developments, impact and challenges. Biochimie 128\u2013129:99\u2013112. https:\/\/doi.org\/10.1016\/j.biochi.2016.07.008","journal-title":"Biochimie"},{"key":"4002_CR56","first-page":"36","volume":"31","author":"S Jiamton","year":"2013","unstructured":"Jiamton S, Tangjaturonrusamee C, Kulthanan K (2013) Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol 31:36\u201342","journal-title":"Asian Pac J Allergy Immunol"},{"key":"4002_CR57","doi-asserted-by":"publisher","unstructured":"Johnson BB, Franco AI, Beck LA, Prezzano JC (2019) Treatment-resistant atopic dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol 181\u2013192. https:\/\/doi.org\/10.2147\/CCID.S163814","DOI":"10.2147\/CCID.S163814"},{"issue":"12","key":"4002_CR58","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s13555-022-00829-4","volume":"12","author":"H Johnson","year":"2022","unstructured":"Johnson H, Yu J (2022) Current and emerging therapies in pediatric atopic dermatitis. Dermatol Ther 12(12):2691\u20132703. https:\/\/doi.org\/10.1007\/s13555-022-00829-4","journal-title":"Dermatol Ther"},{"issue":"10","key":"4002_CR59","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1080\/03639045.2018.1492607","volume":"44","author":"V Kakkar","year":"2018","unstructured":"Kakkar V, Kaur IP, Kaur AP, Saini K, Singh KK (2018) Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study. Drug Dev Ind Pharm 44(10):1701\u20131712. https:\/\/doi.org\/10.1080\/03639045.2018.1492607","journal-title":"Drug Dev Ind Pharm"},{"key":"4002_CR60","doi-asserted-by":"publisher","unstructured":"Kakkar V, Kumar M, Saini K (2019) An overview of atopic dermatitis with a focus on nano-interventions. EMJ Innov 44\u201354. https:\/\/doi.org\/10.33590\/emjinnov\/10311773","DOI":"10.33590\/emjinnov\/10311773"},{"issue":"5","key":"4002_CR61","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s43440-023-00510-3","volume":"75","author":"V Kakkar","year":"2023","unstructured":"Kakkar V, Saini K, Singh KK (2023) Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis. Pharmacol Rep 75(5):1066\u20131095. https:\/\/doi.org\/10.1007\/s43440-023-00510-3","journal-title":"Pharmacol Rep"},{"issue":"S2","key":"4002_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13223-018-0281-6","volume":"14","author":"S Kapur","year":"2018","unstructured":"Kapur S, Watson W, Carr S (2018) Atopic dermatitis. Allergy Asthma Clin Immunol 14(S2):52. https:\/\/doi.org\/10.1186\/s13223-018-0281-6","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"4002_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/1346-8138.15090","volume":"46","author":"N Katoh","year":"2019","unstructured":"Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K (2019) Clinical practice guidelines for the management of atopic dermatitis 2018. J Dermatol 46(12):1053\u20131101. https:\/\/doi.org\/10.1111\/1346-8138.15090","journal-title":"J Dermatol"},{"issue":"59","key":"4002_CR64","doi-asserted-by":"publisher","first-page":"37413","DOI":"10.1039\/D1RA06283B","volume":"11","author":"T Kazim","year":"2021","unstructured":"Kazim T, Tariq A, Usman M, Ayoob MF, Khan A (2021) Chitosan hydrogel for topical delivery of ebastine loaded solid lipid nanoparticles for alleviation of allergic contact dermatitis. RSC Adv 11(59):37413\u201337425. https:\/\/doi.org\/10.1039\/D1RA06283B","journal-title":"RSC Adv"},{"issue":"4","key":"4002_CR65","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1166\/jbn.2009.1053","volume":"5","author":"CM Keck","year":"2009","unstructured":"Keck CM, Schwabe K (2009) Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, <I>In Vivo<\/I> efficiency and theory of action. J Biomed Nanotechnol 5(4):428\u2013436. https:\/\/doi.org\/10.1166\/jbn.2009.1053","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"4002_CR66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/gels8020129","volume":"8","author":"AS Khan","year":"2022","unstructured":"Khan AS, Shah KU, Mohaini MA, Alsalman AJ, Hawaj MAA, Alhashem YN, Ghazanfar S, Khan KA, Niazi ZR, Farid A (2022) Tacrolimus-loaded solid lipid nanoparticle gel: formulation development and in vitro assessment for topical applications. Gels 8(2):129. https:\/\/doi.org\/10.3390\/gels8020129","journal-title":"Gels"},{"issue":"3","key":"4002_CR67","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V (2023) An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull 13(3):446\u2013460. https:\/\/doi.org\/10.34172\/apb.2023.056","journal-title":"Adv Pharm Bull"},{"key":"4002_CR68","doi-asserted-by":"publisher","first-page":"102652","DOI":"10.1016\/j.jddst.2021.102652","volume":"64","author":"I Kildaci","year":"2021","unstructured":"Kildaci I, Budama-Kilinc Y, Kecel-Gunduz S, Altuntas E (2021) Linseed oil nanoemulsions for treatment of atopic dermatitis disease: formulation, characterization, in vitro and in silico evaluations. J Drug Deliv Sci Technol 64:102652. https:\/\/doi.org\/10.1016\/j.jddst.2021.102652","journal-title":"J Drug Deliv Sci Technol"},{"key":"4002_CR69","unstructured":"Kim C-K, Kim ST, Jang D-J, Kim JH, Park JY, Lim JS, Lee SY, Lee K-M, Lim S-J (2009) Topical administration of cyclosporin A in a solid lipid nanoparticle formulation (8):510\u2013514"},{"issue":"1","key":"4002_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/08982104.2021.1880436","volume":"32","author":"P Kumar","year":"2022","unstructured":"Kumar P, Sharma DK, Ashawat MS (2022) Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: development, characterization, and in vivo investigation using BALB\/c mice model. J Liposome Res 32(1):62\u201373. https:\/\/doi.org\/10.1080\/08982104.2021.1880436","journal-title":"J Liposome Res"},{"issue":"4","key":"4002_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/cosmetics11040113","volume":"11","author":"AK Kurebayashi","year":"2024","unstructured":"Kurebayashi AK, Phan K, Abdoh A, Andreo-Filho N, Lopes PS, Mohammed Y, Leite-Silva VR (2024) Strategic approaches in formulation development for atopic dermatitis. Cosmetics 11(4):113. https:\/\/doi.org\/10.3390\/cosmetics11040113","journal-title":"Cosmetics"},{"issue":"8","key":"4002_CR72","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/jcm13082185","volume":"13","author":"M Lazar","year":"2024","unstructured":"Lazar M, Zhang AD, Vashi NA (2024) Topical treatments in atopic dermatitis: an expansive review. J Clin Med 13(8):2185. https:\/\/doi.org\/10.3390\/jcm13082185","journal-title":"J Clin Med"},{"issue":"3","key":"4002_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4168\/aair.2016.8.3.181","volume":"8","author":"JH Lee","year":"2016","unstructured":"Lee JH, Son SW, Cho SH (2016) A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res 8(3):181. https:\/\/doi.org\/10.4168\/aair.2016.8.3.181","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"4002_CR74","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2013.09.005","volume":"8","author":"W Lei","year":"2013","unstructured":"Lei W, Yu C, Lin H, Zhou X (2013) Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. Asian J Pharm Sci 8(6):336\u2013345. https:\/\/doi.org\/10.1016\/j.ajps.2013.09.005","journal-title":"Asian J Pharm Sci"},{"issue":"4","key":"4002_CR75","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","volume":"134","author":"DYM Leung","year":"2014","unstructured":"Leung DYM, Guttman-Yassky E (2014) Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches. J Allergy Clin Immunol 134(4):769\u2013779. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.008","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"4002_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12016-021-08875-0","volume":"61","author":"Y Li","year":"2021","unstructured":"Li Y, Li L (2021) Contact Dermatitis: Classifications and Management. Clin Rev Allergy Immunol 61(3):245\u2013281. https:\/\/doi.org\/10.1007\/s12016-021-08875-0","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"4002_CR77","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1159\/000518541","volume":"238","author":"C Li","year":"2022","unstructured":"Li C, Sun X, Zhao K, Meng F, Li L, Mu Z, Han X (2022) Efficacy and safety of janus kinase inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis. Dermatology 238(4):725\u2013735. https:\/\/doi.org\/10.1159\/000518541","journal-title":"Dermatology"},{"issue":"1","key":"4002_CR78","first-page":"7","volume":"1","author":"MA Lingan","year":"2011","unstructured":"Lingan MA, Sathali AAH, Kumar MV, Gokila A (2011) Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Revs Chem Commun 1(1):7\u201317","journal-title":"Sci Revs Chem Commun"},{"key":"4002_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2147\/CCID.S289716","volume":"14","author":"ZM Lipman","year":"2021","unstructured":"Lipman ZM, Labib A, Yosipovitch G (2021) Current clinical options for the management of itch in atopic dermatitis. Clin Cosmet Investig Dermatol 14:959\u2013969. https:\/\/doi.org\/10.2147\/CCID.S289716","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"4002_CR80","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","volume":"27","author":"P Liu","year":"2022","unstructured":"Liu P, Chen G, Zhang J (2022) A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules 27(4):1372. https:\/\/doi.org\/10.3390\/molecules27041372","journal-title":"Molecules"},{"issue":"4","key":"4002_CR81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/ph15040459","volume":"15","author":"J Ma","year":"2022","unstructured":"Ma J, Wang Y, Lu R (2022) Mechanism and application of chitosan and its derivatives in promoting permeation in transdermal drug delivery systems: a review. Pharmaceuticals 15(4):459. https:\/\/doi.org\/10.3390\/ph15040459","journal-title":"Pharmaceuticals"},{"key":"4002_CR82","doi-asserted-by":"publisher","unstructured":"Mall J, Naseem N, Haider MdF, Rahman MA, Khan S, Siddiqui SN (2024) Nanostructured lipid carriers as a drug delivery system: a comprehensive review with therapeutic applications. Intell Pharm S2949866X24001023. https:\/\/doi.org\/10.1016\/j.ipha.2024.09.005","DOI":"10.1016\/j.ipha.2024.09.005"},{"issue":"3","key":"4002_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.31069\/japsr.v4i3.2","volume":"4","author":"GP Malode","year":"2022","unstructured":"Malode GP, Chauhan SA, Bartare SA, Malode LM, Manwar JV, Bakal RL (2022) A critical review on nanoemulsion: advantages, techniques and characterization. J Appl Pharm Sci Res 4(3):6\u201312. https:\/\/doi.org\/10.31069\/japsr.v4i3.2","journal-title":"J Appl Pharm Sci Res"},{"issue":"18","key":"4002_CR84","doi-asserted-by":"publisher","first-page":"9730","DOI":"10.3390\/ijms22189730","volume":"22","author":"SE Mangion","year":"2021","unstructured":"Mangion SE, Holmes AM, Roberts MS (2021) Targeted delivery of zinc pyrithione to skin epithelia. Int J Mol Sci 22(18):9730. https:\/\/doi.org\/10.3390\/ijms22189730","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4002_CR85","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/pharmaceutics15061724","volume":"15","author":"MP Marques","year":"2023","unstructured":"Marques MP, Varela C, Mendon\u00e7a L, Cabral C (2023) Nanotechnology-based topical delivery of natural products for the management of atopic dermatitis. Pharmaceutics 15(6):1724. https:\/\/doi.org\/10.3390\/pharmaceutics15061724","journal-title":"Pharmaceutics"},{"key":"4002_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-024-01542-9","author":"M Mart\u00ednez-Navarrete","year":"2024","unstructured":"Mart\u00ednez-Navarrete M, Guillot AJ, Lobita MC, Recio MC, Giner R, Aparicio-Blanco J, Montesinos MC, Santos HA, Melero A (2024) Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-024-01542-9","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"4002_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.adengl.2020.03.001","volume":"111","author":"M Munera-Campos","year":"2020","unstructured":"Munera-Campos M, Carrascosa JM (2020) Innovation in atopic dermatitis: from pathogenesis to treatment. Actas Dermosifiliogr (English Edition) 111(3):205\u2013221. https:\/\/doi.org\/10.1016\/j.adengl.2020.03.001","journal-title":"Actas Dermosifiliogr (English Edition)"},{"issue":"2","key":"4002_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/pharmaceutics14020383","volume":"14","author":"AB Nair","year":"2022","unstructured":"Nair AB, Kumar S, Dalal P, Nagpal C, Dalal S, Rao R, Sreeharsha N, Jacob S (2022) Novel dermal delivery cargos of clobetasol propionate: an update. Pharmaceutics 14(2):383. https:\/\/doi.org\/10.3390\/pharmaceutics14020383","journal-title":"Pharmaceutics"},{"issue":"3","key":"4002_CR89","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000445776","volume":"29","author":"RHH Neubert","year":"2016","unstructured":"Neubert RHH, Sonnenberger S, Dobner B, Gray CW Jr, Barger KN, Sevi-Maxwell K, Sommer E, Wohlrab J (2016) Controlled penetration of a novel dimeric ceramide into and across the stratum corneum using microemulsions and various types of semisolid formulations. Skin Pharmacol Physiol 29(3):130\u2013134. https:\/\/doi.org\/10.1159\/000445776","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"4002_CR90","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12247-020-09465-x","volume":"16","author":"RR Pal","year":"2021","unstructured":"Pal RR, Maurya AK, Parashar P, Saraf SA (2021) A comparative study of Levocetirizine loaded vesicular and matrix type system for topical application: appraisal of therapeutic potential against atopic dermatitis. J Pharm Innov 16(3):469\u2013480. https:\/\/doi.org\/10.1007\/s12247-020-09465-x","journal-title":"J Pharm Innov"},{"issue":"3","key":"4002_CR91","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS, Eichenfield LF, Forsha DW, Rees WC, Simpson EL, Spellman MC, Stein Gold LF, Zaenglein AL, Hughes MH, Zane LT, Hebert AA (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75(3):494-503.e6. https:\/\/doi.org\/10.1016\/j.jaad.2016.05.046","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4002_CR92","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13346-018-0480-1","volume":"9","author":"M Pandey","year":"2019","unstructured":"Pandey M, Choudhury H, Gunasegaran TAP, Nathan SS, Md S, Gorain B, Tripathy M, Hussain Z (2019) Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Drug Deliv Transl Res 9(2):520\u2013533. https:\/\/doi.org\/10.1007\/s13346-018-0480-1","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"4002_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejpb.2012.02.008","volume":"81","author":"D Paolino","year":"2012","unstructured":"Paolino D, Celia C, Trapasso E, Cilurzo F, Fresta M (2012) Paclitaxel-loaded ethosomes\u00ae: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses. Eur J Pharm Biopharm 81(1):102\u2013112. https:\/\/doi.org\/10.1016\/j.ejpb.2012.02.008","journal-title":"Eur J Pharm Biopharm"},{"key":"4002_CR94","doi-asserted-by":"publisher","first-page":"121079","DOI":"10.1016\/j.ijpharm.2021.121079","volume":"608","author":"K Parekh","year":"2021","unstructured":"Parekh K, Hariharan K, Qu Z, Rewatkar P, Cao Y, Moniruzzaman Md, Pandey P, Popat A, Mehta T (2021a) Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis. Int J Pharm 608:121079. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121079","journal-title":"Int J Pharm"},{"issue":"2","key":"4002_CR95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1208\/s12249-021-01920-3","volume":"22","author":"K Parekh","year":"2021","unstructured":"Parekh K, Mehta TA, Dhas N, Kumar P, Popat A (2021b) Emerging nanomedicines for the treatment of atopic dermatitis. AAPS PharmSciTech 22(2):55. https:\/\/doi.org\/10.1208\/s12249-021-01920-3","journal-title":"AAPS PharmSciTech"},{"key":"4002_CR96","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jdcr.2022.04.003","volume":"24","author":"E Pope","year":"2022","unstructured":"Pope E, Kowalski E, Tausk F (2022) Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis. JAAD Case Reports 24:59\u201360. https:\/\/doi.org\/10.1016\/j.jdcr.2022.04.003","journal-title":"JAAD Case Reports"},{"issue":"4","key":"4002_CR97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/17425247.2012.666967","volume":"9","author":"C Puglia","year":"2012","unstructured":"Puglia C, Bonina F (2012) Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv 9(4):429\u2013441. https:\/\/doi.org\/10.1517\/17425247.2012.666967","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"4002_CR98","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1208\/s12249-016-0692-y","volume":"18","author":"W Qing","year":"2017","unstructured":"Qing W, Wang Y, Li H, Ma F, Zhu J, Liu X (2017) Preparation and characterization of copolymer micelles for the solubilization and in vitro release of luteolin and luteoloside. AAPS PharmSciTech 18(6):2095\u20132101. https:\/\/doi.org\/10.1208\/s12249-016-0692-y","journal-title":"AAPS PharmSciTech"},{"key":"4002_CR99","doi-asserted-by":"publisher","first-page":"173691","DOI":"10.1016\/j.ejphar.2020.173691","volume":"890","author":"AK Ramanunny","year":"2021","unstructured":"Ramanunny AK, Wadhwa S, Gulati M, Singh SK, Kapoor B, Dureja H, Chellappan DK, Anand K, Dua K, Khursheed R, Awasthi A, Kumar R, Kaur J, Corrie L, Pandey NK (2021) Nanocarriers for treatment of dermatological diseases: principle, perspective and practices. Eur J Pharmacol 890:173691. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173691","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"4002_CR100","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/17425247.2020.1813107","volume":"17","author":"EV Ramos Campos","year":"2020","unstructured":"Ramos Campos EV, Proen\u00e7a PLDF, Doretto-Silva L, Andrade-Oliveira V, Fraceto LF, De Araujo DR (2020) Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv 17(11):1615\u20131630. https:\/\/doi.org\/10.1080\/17425247.2020.1813107","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"4002_CR101","doi-asserted-by":"publisher","first-page":"244","DOI":"10.36849\/JDD.2020.4737","volume":"19","author":"M Reynolds","year":"2020","unstructured":"Reynolds M, Gorelick J, Bruno M (2020) Atopic dermatitis: a review of current diagnostic criteria and a proposed update to management. J Drugs Dermatol 19(3):244\u2013248. https:\/\/doi.org\/10.36849\/JDD.2020.4737","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"4002_CR102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.clindermatol.2017.03.009","volume":"35","author":"CW Rundle","year":"2017","unstructured":"Rundle CW, Bergman D, Goldenberg A, Jacob SE (2017) Contact dermatitis considerations in atopic dermatitis. Clin Dermatol 35(4):367\u2013374. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.009","journal-title":"Clin Dermatol"},{"issue":"1\u20132","key":"4002_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijpharm.2016.11.029","volume":"516","author":"FF Sahle","year":"2017","unstructured":"Sahle FF, Gerecke C, Kleuser B, Bodmeier R (2017) Formulation and comparative in vitro evaluation of various dexamethasone-loaded pH-sensitive polymeric nanoparticles intended for dermal applications. Int J Pharm 516(1\u20132):21\u201331. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.029","journal-title":"Int J Pharm"},{"key":"4002_CR104","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","volume":"51","author":"VR Salvi","year":"2019","unstructured":"Salvi VR, Pawar P (2019) Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier. J Drug Deliv Sci Technol 51:255\u2013267. https:\/\/doi.org\/10.1016\/j.jddst.2019.02.017","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"4002_CR105","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics12030246","volume":"12","author":"P Shah","year":"2020","unstructured":"Shah P, Goodyear B, Haq A, Puri V, Michniak-Kohn B (2020) Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. Pharmaceutics 12(3):246. https:\/\/doi.org\/10.3390\/pharmaceutics12030246","journal-title":"Pharmaceutics"},{"issue":"6","key":"4002_CR106","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s40267-024-01075-8","volume":"40","author":"H Shah","year":"2024","unstructured":"Shah H, Eckembrecher FJ, Eckembrecher DG, Nouri K (2024) Current and emerging immunobiologic therapies for atopic dermatitis. Drugs Ther Perspect 40(6):226\u2013237. https:\/\/doi.org\/10.1007\/s40267-024-01075-8","journal-title":"Drugs Ther Perspect"},{"issue":"8","key":"4002_CR107","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10856-021-06558-y","volume":"32","author":"K Shetty","year":"2021","unstructured":"Shetty K, Sherje AP (2021) Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis\u2014a systematic review. J Mater Sci Mater Med 32(8):88. https:\/\/doi.org\/10.1007\/s10856-021-06558-y","journal-title":"J Mater Sci Mater Med"},{"issue":"7","key":"4002_CR108","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1080\/21691401.2017.1373659","volume":"46","author":"S Shrotriya","year":"2018","unstructured":"Shrotriya S, Ranpise N, Satpute P, Vidhate B (2018) Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Artif Cells Nanomed Biotechnol 46(7):1471\u20131482. https:\/\/doi.org\/10.1080\/21691401.2017.1373659","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"4002_CR109","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","volume":"71","author":"R Sidbury","year":"2014","unstructured":"Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF (2014) Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol 71(2):327\u2013349. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.030","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4002_CR110","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","volume":"89","author":"R Sidbury","year":"2023","unstructured":"Sidbury R, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Drucker AM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Davis DMR (2023) Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol 89(1):e1\u2013e20. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.029","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"4002_CR111","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.3390\/jcm11174974","volume":"11","author":"N Sideris","year":"2022","unstructured":"Sideris N, Paschou E, Bakirtzi K, Kiritsi D, Papadimitriou I, Tsentemeidou A, Sotiriou E, Vakirlis E (2022) New and upcoming topical treatments for atopic dermatitis: a review of the literature. J Clin Med 11(17):4974. https:\/\/doi.org\/10.3390\/jcm11174974","journal-title":"J Clin Med"},{"issue":"4","key":"4002_CR112","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clindermatol.2017.03.007","volume":"35","author":"NB Silverberg","year":"2017","unstructured":"Silverberg NB (2017) Typical and atypical clinical appearance of atopic dermatitis. Clin Dermatol 35(4):354\u2013359. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.007","journal-title":"Clin Dermatol"},{"key":"4002_CR113","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/ITT.S229667","volume":"9","author":"R Singh","year":"2020","unstructured":"Singh R, Heron CE, Ghamrawi RI, Strowd LC, Feldman SR (2020) Emerging role of janus kinase inhibitors for the treatment of atopic dermatitis. Immunotargets Ther 9:255\u2013272. https:\/\/doi.org\/10.2147\/ITT.S229667","journal-title":"Immunotargets Ther"},{"issue":"1","key":"4002_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/gels10010079","volume":"10","author":"M Slavkova","year":"2024","unstructured":"Slavkova M, Lazov C, Spassova I, Kovacheva D, Tibi IP-E, Stefanova D, Tzankova V, Petrov PD, Yoncheva K (2024) Formulation of Budesonide-loaded polymeric nanoparticles into hydrogels for local therapy of atopic dermatitis. Gels 10(1):79. https:\/\/doi.org\/10.3390\/gels10010079","journal-title":"Gels"},{"key":"4002_CR115","doi-asserted-by":"publisher","first-page":"173242","DOI":"10.1016\/j.ejphar.2020.173242","volume":"881","author":"M Soeberdt","year":"2020","unstructured":"Soeberdt M, Kilic A, Abels C (2020) Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis. Eur J Pharmacol 881:173242. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173242","journal-title":"Eur J Pharmacol"},{"key":"4002_CR116","doi-asserted-by":"publisher","unstructured":"Stefanovic N, Irvine AD (2023) Filaggrin and beyond. Ann Allergy Asthma Immunol S1081120623012656. https:\/\/doi.org\/10.1016\/j.anai.2023.09.009","DOI":"10.1016\/j.anai.2023.09.009"},{"issue":"3","key":"4002_CR117","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/antiox12030633","volume":"12","author":"E Subroto","year":"2023","unstructured":"Subroto E, Andoyo R, Indiarto R (2023) Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants 12(3):633. https:\/\/doi.org\/10.3390\/antiox12030633","journal-title":"Antioxidants"},{"issue":"8","key":"4002_CR118","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/ijms21082671","volume":"21","author":"R Tamagawa-Mineoka","year":"2020","unstructured":"Tamagawa-Mineoka R, Katoh N (2020) Atopic dermatitis: identification and management of complicating factors. Int J Mol Sci 21(8):2671. https:\/\/doi.org\/10.3390\/ijms21082671","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4002_CR119","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","volume":"53","author":"RK Thapa","year":"2023","unstructured":"Thapa RK, Kim JO (2023) Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Investig 53(1):19\u201333. https:\/\/doi.org\/10.1007\/s40005-022-00607-6","journal-title":"J Pharm Investig"},{"issue":"3","key":"4002_CR120","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1439-0507.2009.01814.x","volume":"53","author":"A Tragiannidis","year":"2010","unstructured":"Tragiannidis A, Bisping G, Koehler G, Groll AH (2010) Minireview: Malassezia infections in immunocompromised patients. Mycoses 53(3):187\u2013195. https:\/\/doi.org\/10.1111\/j.1439-0507.2009.01814.x","journal-title":"Mycoses"},{"issue":"4","key":"4002_CR121","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/jpm11040279","volume":"11","author":"H-R Tsai","year":"2021","unstructured":"Tsai H-R, Lu J-W, Chen L-Y, Chen T-L (2021) Application of Janus kinase inhibitors in atopic dermatitis: an updated systematic review and meta-analysis of clinical trials. J Personalized Med 11(4):279. https:\/\/doi.org\/10.3390\/jpm11040279","journal-title":"J Personalized Med"},{"issue":"9","key":"4002_CR122","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/1061186X.2021.1898621","volume":"29","author":"DL Vale","year":"2021","unstructured":"Vale DL, Martinez RM, Medeiros DC, Da Rocha C, Sfeir N, Lopez RFV, Vicentini FTMC, Verri WA, Georgetti SR, Baracat MM, Casagrande R (2021) A topical formulation containing quercetin-loaded microcapsules protects against oxidative and inflammatory skin alterations triggered by UVB irradiation: enhancement of activity by microencapsulation. J Drug Target 29(9):983\u2013997. https:\/\/doi.org\/10.1080\/1061186X.2021.1898621","journal-title":"J Drug Target"},{"issue":"5","key":"4002_CR123","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S2352-4642(19)30030-6","volume":"3","author":"PP Vakharia","year":"2019","unstructured":"Vakharia PP, Silverberg JI (2019) New and emerging therapies for paediatric atopic dermatitis. Lancet Child Adolesc Health. 3(5):343\u2013353. https:\/\/doi.org\/10.1016\/S2352-4642(19)30030-6","journal-title":"Lancet Child Adolesc Health."},{"issue":"6","key":"4002_CR124","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.adengl.2016.05.002","volume":"107","author":"I V\u00e1zquez-Osorio","year":"2016","unstructured":"V\u00e1zquez-Osorio I, Gonz\u00e1lez-Sab\u00edn M, Gonzalvo-Rodr\u00edguez P, Rodr\u00edguez-D\u00edaz E (2016) Annular lichenoid dermatitis of youth: a report of 2 cases and a review of the literature. Actas Dermosifiliogr (English Edition) 107(6):e39\u2013e45. https:\/\/doi.org\/10.1016\/j.adengl.2016.05.002","journal-title":"Actas Dermosifiliogr (English Edition)"},{"issue":"6","key":"4002_CR125","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"C Viegas","year":"2023","unstructured":"Viegas C, Patr\u00edcio AB, Prata JM, Nadhman A, Chintamaneni PK, Fonte P (2023) Solid lipid nanoparticles vs. nanostructured lipid carriers: a comparative review. Pharmaceutics 15(6):1593. https:\/\/doi.org\/10.3390\/pharmaceutics15061593","journal-title":"Pharmaceutics"},{"issue":"7","key":"4002_CR126","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1208\/s12249-020-01831-9","volume":"21","author":"T Waghule","year":"2020","unstructured":"Waghule T, Gorantla S, Rapalli VK, Shah P, Dubey SK, Saha RN, Singhvi G (2020) Emerging trends in topical delivery of curcumin through lipid nanocarriers: effectiveness in skin disorders. AAPS PharmSciTech 21(7):284. https:\/\/doi.org\/10.1208\/s12249-020-01831-9","journal-title":"AAPS PharmSciTech"},{"key":"4002_CR127","doi-asserted-by":"publisher","first-page":"106680","DOI":"10.1016\/j.ejps.2023.106680","volume":"193","author":"Y Xia","year":"2024","unstructured":"Xia Y, Cao K, Jia R, Chen X, Wu Y, Wang Y, Cheng Z, Xia H, Xu Y, Xie Z (2024) Tetramethylpyrazine-loaded liposomes surrounded by hydrogel based on sodium alginate and chitosan as a multifunctional drug delivery System for treatment of atopic dermatitis. Eur J Pharm Sci 193:106680. https:\/\/doi.org\/10.1016\/j.ejps.2023.106680","journal-title":"Eur J Pharm Sci"},{"key":"4002_CR128","doi-asserted-by":"publisher","first-page":"775018","DOI":"10.3389\/fimmu.2021.775018","volume":"12","author":"B Xu","year":"2021","unstructured":"Xu B, Ling S, Xu X, Liu X, Wang A, Zhou Y, Luo Y, Li W, Yao X (2021) A new formulation of probiotics attenuates calcipotriol-induced dermatitis by inducing regulatory dendritic cells. Front Immunol 12:775018. https:\/\/doi.org\/10.3389\/fimmu.2021.775018","journal-title":"Front Immunol"},{"issue":"1","key":"4002_CR129","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12951-017-0323-0","volume":"15","author":"M Yang","year":"2017","unstructured":"Yang M, Gu Y, Yang D, Tang X, Liu J (2017) Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics. J Nanobiotechnol 15(1):88. https:\/\/doi.org\/10.1186\/s12951-017-0323-0","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4002_CR130","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijpharm.2005.10.002","volume":"307","author":"E Yilmaz","year":"2006","unstructured":"Yilmaz E, Borchert H-H (2006) Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema\u2014An in vivo study. Int J Pharm 307(2):232\u2013238. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.002","journal-title":"Int J Pharm"},{"issue":"2","key":"4002_CR131","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40257-022-00753-5","volume":"24","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Nedorost ST, Silverberg JI, Friedman AJ, Canosa JM, Cha A (2023) Stasis dermatitis: an overview of its clinical presentation, pathogenesis, and management. Am J Clin Dermatol 24(2):275\u2013286. https:\/\/doi.org\/10.1007\/s40257-022-00753-5","journal-title":"Am J Clin Dermatol"},{"key":"4002_CR132","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.carbpol.2018.06.023","volume":"197","author":"F Zhuo","year":"2018","unstructured":"Zhuo F, Abourehab MAS, Hussain Z (2018) Hyaluronic acid decorated tacrolimus-loaded nanoparticles: efficient approach to maximize dermal targeting and anti-dermatitis efficacy. Carbohyd Polym 197:478\u2013489. https:\/\/doi.org\/10.1016\/j.carbpol.2018.06.023","journal-title":"Carbohyd Polym"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04002-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:37:06Z","timestamp":1757144226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":132,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4002"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04002-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable; review paper did not involve any clinical trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}